|
Q1 FY2027
As of Sep 30, 2026
|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||
| Website | |||||||||
| Prepaid Expenses | |||||||||
| Accounts Receivables | |||||||||
| Total current assets | |||||||||
| Intangible Assets | |||||||||
| Assets in Progress | |||||||||
| Computer | |||||||||
| Website | |||||||||
| Computer | |||||||||
| Total non - current assets | |||||||||
| Total non- current assets | |||||||||
| TOTAL ASSETS | |||||||||
| Current Liabilities | |||||||||
| Advances from related party | |||||||||
| Deferred Revenue | |||||||||
| Accounts Payable | |||||||||
| Total current liabilities | |||||||||
| Total Liabilities | |||||||||
| Stockholders' Equity / (Deficit) | |||||||||
| Common stock, $0.001 par value, 75,000,000 shares authorized; 3,623,080 shares issued and outstanding | |||||||||
| Additional paid-in-capital | |||||||||
| Accumulated deficit | |||||||||
| Total Stockholders' Equity | |||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
